Molbio Diagnostics

Health Tech & Medtech · Mormugao, India · Founded 2000

Enabling better medicine through precise, rapid, cost-effective molecular diagnosis at the Point of Care MoreLess

Molbio Diagnostics specializes in developing and manufacturing advanced chip-based Real Time Polymerase Chain Reaction (PCR) diagnostic tests. The company serves healthcare providers, hospitals, and diagnostic labs, offering solutions for rapid and accurate detection of infectious diseases such as tuberculosis, COVID-19, H1N1, HPV, Salmonella, and HIV. Operating in the global healthcare diagnostics market, Molbio's business model revolves around the sale of disposable, room temperature stable diagnostic chips and automated PCR analyzers. Revenue is generated through the direct sale of these diagnostic products and associated consumables. The company's flagship product line, TrueNat, is endorsed by the World Health Organization and validated by the Indian Council of Medical Research, highlighting its reliability and effectiveness. Molbio's solutions are designed to be user-friendly, enabling quick and precise diagnostics even in resource-limited settings, thereby improving patient outcomes and aiding in the control of infectious diseases.

Keywords: PCR diagnostics, infectious diseases, TrueNat, tuberculosis, COVID-19, H1N1, HPV, Salmonella, HIV, healthcare diagnostics.

Valuation $1–2.5B

Revenue $100–500M

Headcount 500–1k

Total funding $100–500M

Unlock exact values

Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue

Knowledge graph

News Molbio Diagnostics raises Rs 281 crore from anchor investors ahead of IPO Aug 8, 2026

Talent graph

Molbio Diagnostics's talent

Book a demo to see the people

Team profiled 4 named & role-tagged

Founders /100 quality score

Key operators 4 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

2 investors on Molbio Diagnostics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage

Motilal Oswal Private Wealth Management

Temasek

Global footprint

Where Molbio Diagnostics has talent and traffic

Workforce by country

15 countries with
team presence

🇮🇳 India94.7%

🇬🇧 United Kingdom0.5%

🇺🇸 United States0.5%

🇿🇦 South Africa0.5%

🇪🇹 Ethiopia0.5%

Top 5 of 15 shown

Web traffic by country

13K monthly visits
across markets

🇮🇳 India90.8%

🇺🇸 United States6.9%

🇵🇭 Philippines1.5%

🇳🇵 Nepal0.8%

Top 4 markets shown

Market sentiment

What the market is saying about Molbio Diagnostics

An AI-synthesized read of the highest-engagement posts about Molbio Diagnostics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Molbio Diagnostics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles